Home
Conditions
Cerebral Small Vessel Diseases

Clinical trial condition

Cerebral Small Vessel Diseases

Explore clinical trials studying Cerebral Small Vessel Diseases. Study availability and eligibility vary by location and protocol.

282 public trials 64 recruiting studies

Refine in advanced search Browse all conditions

Cerebral Small Vessel Diseases trial results

Completed

Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

NCT00925301

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Los Angeles, California, United States

San Francisco, California, United States

Decatur, Georgia, United States

Chicago, Illinois, United States

View all 28 locations

View Trial Details

Completed

Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy

NCT02908724

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +31 more
Locations: Not specified

View Trial Details

Completed

Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance

NCT02969200

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
Locations: National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark

View Trial Details

Completed

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease

NCT00304512

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Decatur, Georgia, United States

Parkville, Victoria, Australia

Porto Alegre, Brazil

Montreal, Canada

View Trial Details

Completed

A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

NCT00283933

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Paris, France

London, United Kingdom

View Trial Details

Completed

Fabry Disease Screening in ESRD Patients in West of France

NCT02719249

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +33 more
Locations: CHU de Rennes Rennes, France

View Trial Details

Completed

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations: Mayo Clinic Arizona Scottsdale, Arizona, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Mayo Clinic Jacksonville, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

View all 15 locations

View Trial Details

Completed

A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease

NCT02930655

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Investigator Site Würzburg, Germany

View Trial Details

Completed

Journey of Patients With Vasculitis From First Symptom to Diagnosis

NCT03410290

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +65 more
Locations: University of South Florida Tampa, Florida, United States

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

NCT03056209

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Seoul National University Hospital Seoul, Jongno-gu, South Korea

View Trial Details

Cerebral Small Vessel Diseases

Cerebral Small Vessel Diseases trial results

Related conditions